Myelodysplastic Syndromes News and Research

RSS
FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Study reveals why survival for blood cancer patients still varies between regions within Europe

Study reveals why survival for blood cancer patients still varies between regions within Europe

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Study shows critical role of immune system in protecting against viruses and cancer cells

Study shows critical role of immune system in protecting against viruses and cancer cells

FDA removes partial clinical hold on Cell Therapeutics' Tosedostat aminopeptidase inhibitor

FDA removes partial clinical hold on Cell Therapeutics' Tosedostat aminopeptidase inhibitor

Researchers discover control mechanism that can trigger development of MDS

Researchers discover control mechanism that can trigger development of MDS

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

New study provides guidelines for stem cell transplantation in older MDS patients

New study provides guidelines for stem cell transplantation in older MDS patients

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Onconova reports positive results from rigosertib Phase 1 trial in patients with advanced solid tumors

Onconova reports positive results from rigosertib Phase 1 trial in patients with advanced solid tumors

MD Anderson professor to receive award for clinical research excellence at AACR meeting

MD Anderson professor to receive award for clinical research excellence at AACR meeting

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Elsevier announces launch of Leukemia Research Reports journal

Elsevier announces launch of Leukemia Research Reports journal

Array BioPharma first quarter 2013 revenue decreases to $15.8 million

Array BioPharma first quarter 2013 revenue decreases to $15.8 million

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Abnormal bone marrow stem cells drive development of myelodysplastic syndromes

Abnormal bone marrow stem cells drive development of myelodysplastic syndromes

NewYork-Presbyterian/WCMC join new MDS Clinical Research Consortium

NewYork-Presbyterian/WCMC join new MDS Clinical Research Consortium

Onconova advances rigosertib into new Phase II study for refractory MDS

Onconova advances rigosertib into new Phase II study for refractory MDS

Array BioPharma third quarter revenue increases to $19.1M

Array BioPharma third quarter revenue increases to $19.1M